Department of Clinical Epidemiology, Leiden University Medical Center, The Netherlands.
Clin J Am Soc Nephrol. 2013 Sep;8(9):1540-7. doi: 10.2215/CJN.10761012. Epub 2013 Jul 11.
Studies performed in the United States showed that blacks progress from CKD to ESRD faster than do whites. Possible explanations are differences in health care system factors. This study investigated whether progression is also faster in a universal health care system, where all patients receive comparable care.
DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Data from the PREdialysis PAtient REcord study, a multicenter follow-up study of patients with CKD who started predialysis care in The Netherlands (1999-2011), were analyzed. Time-dependent Cox proportional hazards models were used to estimate the hazard ratio (HR) for starting renal replacement therapy (RRT), and linear mixed models were used to compare renal function decline (RFD) between blacks and whites. To explore possible mechanisms, analyses were adjusted for patient characteristics.
At initiation of predialysis care, blacks (n=49) were younger and had more diabetes mellitus, higher proteinuria levels, and a higher estimated GFR than whites (n=946). Median follow-up time in months was similar (blacks: 13.9 [boundaries of interquartile range (IQR), 5.3 to 19.5]; whites: 13.1 [IQR, 5.1 to 24.0]). For blacks compared with whites, the crude HR for starting RRT within the first 15 months was 0.86 (95% confidence interval [CI], 0.55 to 1.34) and from 15 months onward, 1.93 (95% CI, 1.02 to 3.68), which increased after adjustment. RFD was faster by 0.18 (95% CI, 0.05 to 0.32) ml/min per 1.73 m(2) per month in blacks compared with whites.
Blacks receiving predialysis care in a universal health care system have faster disease progression than whites, suggesting that health care system factors have a less influential role than had been thought in explaining black-white differences.
在美国开展的研究显示,黑人从慢性肾脏病(CKD)进展至终末期肾病(ESRD)的速度快于白人。可能的解释是医疗保健系统因素存在差异。本研究旨在调查在全民医疗保健系统中,黑人的进展速度是否也更快,因为在该系统中,所有患者均可获得可比的医疗服务。
设计、地点、参与者和测量:对 PREdialysis PAtient REcord 研究的数据进行了分析,该研究是一项针对在荷兰开始透析前治疗的 CKD 患者的多中心随访研究(1999-2011 年)。采用时间依赖性 Cox 比例风险模型来估计开始肾脏替代治疗(RRT)的风险比(HR),并采用线性混合模型比较黑人和白人之间的肾功能下降(RFD)。为了探讨可能的机制,对患者特征进行了调整。
在开始透析前治疗时,黑人(n=49)比白人(n=946)更年轻,且糖尿病、蛋白尿水平更高,估算肾小球滤过率(eGFR)更低。黑人的中位随访时间为 13.9 个月(四分位间距 [IQR],5.3 至 19.5),白人的中位随访时间为 13.1 个月(IQR,5.1 至 24.0)。与白人相比,黑人在最初 15 个月内开始 RRT 的粗 HR 为 0.86(95%置信区间 [CI],0.55 至 1.34),15 个月后为 1.93(95% CI,1.02 至 3.68),在调整后这一比值增加。黑人的 RFD 每月比白人快 0.18 ml/min/1.73 m²(95% CI,0.05 至 0.32)。
在全民医疗保健系统中接受透析前治疗的黑人比白人的疾病进展速度更快,这表明医疗保健系统因素在解释黑人和白人之间的差异方面的作用比之前认为的要小。